首页> 外国专利> THIENOPYRIDINE DERIVATIVES, QUINOLINE DERIVATIVES AND CHINAZOLINE DERIVATIVES HAVING INHIBITOR ACTIVITY WITH RESPECT TO C-MET AUTOPHOSPHORILATION

THIENOPYRIDINE DERIVATIVES, QUINOLINE DERIVATIVES AND CHINAZOLINE DERIVATIVES HAVING INHIBITOR ACTIVITY WITH RESPECT TO C-MET AUTOPHOSPHORILATION

机译:硫代吡啶衍生物,喹啉衍生物和中唑啉衍生物具有抑制活性,相对于C-MET自磷酸化

摘要

1. The compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof:! [Chemical formula 1]! ! where! R1 represents a hydrogen atom or an unsaturated five- or six-membered heterocyclic group, optionally substituted with C1-4 alkyl, C1-4 alkoxy or a halogen atom! R2 represents a hydrogen atom,! X represents CH or N,! Z represents O or S,! E is absent or represents a substituent in the phenylene group selected from a halogen atom, C1-4 alkyl and C1-4 alkoxy, and the numbers indicate the substitution position,! J represents S or O, and! T represents phenyl optionally substituted with a halogen atom, C1-4 alkyl or C1-4 alkoxy; an unsaturated five- or six-membered heterocyclic group optionally substituted with a halogen atom, C1-4 alkyl or C1-4 alkoxy; or an unsaturated nine- or ten-membered bicyclic carbocyclic or heterocyclic group optionally substituted with a halogen atom, C1-4 alkyl or C1-4 alkoxy. ! 2. The compound according to claim 1, where R1 represents a hydrogen atom or an unsaturated five-membered heterocyclic group, optionally substituted with C1-4 alkyl. ! 3. The compound according to claim 1, where R1 represents a hydrogen atom or imidazolyl, optionally substituted with C1-4 alkyl. ! 4. The compound according to claim 1, where R1 represents a hydrogen atom or 1H-imidazol-2-yl, optionally substituted with C1-4 alkyl. ! 5. The compound according to claim 1, where R1 represents a hydrogen atom or is represented by the formula (a):! [Chemical formula 2]! ! where R3 represents a hydrogen atom or C1-4 alkyl. ! 6. The compound according to claim 1, where X represents CH. ! 7. The compound according to claim 1, where Z represents O.! 8. The compound according to claim 1, where
机译:1.式(I)的化合物或其药学上可接受的盐或溶剂化物: [化学式1]! !哪里! R 1代表氢原子或不饱和的五元或六元杂环基团,其任选地被C 1-4烷基,C 1-4烷氧基或卤素原子取代! R 2代表氢原子! X代表CH或N! Z代表O或S! E不存在或代表选自卤原子,C 1-4烷基和C 1-4烷氧基的亚苯基中的取代基,数字表示取代位置! J代表S或O,并且! T表示任选地被卤素原子,C 1-4烷基或C 1-4烷氧基取代的苯基;任选地被卤素原子,C 1-4烷基或C 1-4烷氧基取代的不饱和五或六元杂环基;或任选地被卤素原子,C 1-4烷基或C 1-4烷氧基取代的不饱和的九元或十元双环碳环或杂环基。 ! 2.根据权利要求1的化合物,其中R1代表氢原子或任选地被C1-4烷基取代的不饱和五元杂环基。 ! 3.根据权利要求1的化合物,其中R1代表氢原子或咪唑基,任选地被C1-4烷基取代。 ! 4.根据权利要求1的化合物,其中R1代表氢原子或1H-咪唑-2-基,其任选地被C1-4烷基取代。 ! 5.根据权利要求1的化合物,其中R1代表氢原子或由式(a)表示: [化学式2]! !其中R3代表氢原子或C1-4烷基。 ! 6.根据权利要求1的化合物,其中X代表CH。 ! 7.根据权利要求1的化合物,其中Z代表O。 8.根据权利要求1的化合物,其中

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号